Legal & General Group Plc - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 96 filers reported holding IMMUNOMEDICS INC in Q4 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$15,111,000
+144.6%
177,719
+2.0%
0.01%
+133.3%
Q2 2020$6,178,000
+294.5%
174,313
+50.1%
0.00%
+200.0%
Q1 2020$1,566,000
-33.8%
116,123
+3.8%
0.00%0.0%
Q4 2019$2,366,000
+87.2%
111,835
+17.3%
0.00%0.0%
Q3 2019$1,264,000
+16.0%
95,354
+21.3%
0.00%0.0%
Q2 2019$1,090,000
-20.9%
78,630
+9.7%
0.00%0.0%
Q1 2019$1,378,000
+65.6%
71,695
+23.0%
0.00%0.0%
Q4 2018$832,000
-17.9%
58,300
+19.7%
0.00%0.0%
Q3 2018$1,014,000
-10.0%
48,707
+2.3%
0.00%0.0%
Q2 2018$1,127,000
+47.3%
47,625
-9.0%
0.00%0.0%
Q1 2018$765,000
+80.9%
52,358
+100.7%
0.00%
Q4 2017$423,000
+12.5%
26,088
-3.3%
0.00%
Q3 2017$376,000
+69.4%
26,991
+5.9%
0.00%
Q2 2017$222,000
+44.2%
25,477
+7.4%
0.00%
Q1 2017$154,000
+65.6%
23,730
-6.3%
0.00%
Q4 2016$93,000
+106.7%
25,313
+79.6%
0.00%
Q3 2016$45,000
+21.6%
14,097
-13.1%
0.00%
Q2 2016$37,000
-9.8%
16,2200.0%0.00%
Q1 2016$41,000
-16.3%
16,2200.0%0.00%
Q4 2015$49,000
+81.5%
16,2200.0%0.00%
Q3 2015$27,000
-57.8%
16,2200.0%0.00%
Q2 2015$64,000
+3.2%
16,2200.0%0.00%
Q1 2015$62,000
-20.5%
16,2200.0%0.00%
Q4 2014$78,000
+30.0%
16,2200.0%0.00%
Q3 2014$60,00016,2200.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders